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Edited by Veli-Pekka LehtoAbstract Tumor endothelial marker 7 (TEM7) is a novel trans-
membrane protein that is highly expressed in the tumor endothe-
lium. However, the ligands and functions of TEM7 are unknown
at present. Using a recombinant ectodomain of TEM7 as a
probe, we could identify the saturable interaction between nido-
gen and TEM7 in vitro. A cell overlay binding assay showed that
recombinant nidogen interact with full length TEM7 on cell sur-
face. Finally, nidogen/TEM7 interaction enhanced cell spreading
in TEM7 transfected 293T cells. This novel nidogen/TEM7
interaction may provide an important molecular tool with poten-
tial therapeutic applications in the anti-angiogenic therapies.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Tumor endothelial markers (TEMs) were originally identi-
ﬁed as genes that displayed elevated expression during tumor
angiogenesis [1,2]. Among TEMs, TEMs associated with the
cell membrane, such as TEM1, 5, 7 and 8, may function as
receptors for extracellular ligand(s), thereby providing attrac-
tive molecular targets for anti-angiogenic therapies [3]. How-
ever, recent in situ hybridization studies have revealed that
TEMs may also play a role in normal tissues [3,4]. For exam-
ple, TEM1, TEM7 and TEM8 mRNAs are found to be ex-
pressed in the developing embryonic vasculature, and we
previously reported that TEM7 mRNA and protein are ex-
pressed in some neurons in the nervous system [4]. Therefore,
TEMs may play a role not only in tumor angiogenesis but also
in certain physiological processes.
In order to understand the function of TEM7 in eukaryotic
cells, elucidation of ligands for the extracellular domain of
TEM7 is essential. It was recently reported that cortactin is a
putative ligand for TEM7 [5]. Even though their biochemical
and co-localization study suggested that the interaction is pos-Abbreviations: TEM7, tumor endothelial marker 7; ECM, extracellular
matrix
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doi:10.1016/j.febslet.2006.03.033sible in tumor endothelium, the relevance of cortactin as a
physiological ligand for the ectodomain of TEM7 is still uncer-
tain because cortactin is an intracellular actin binding protein
[5]. By using an ectodomain of TEM7 conjugated to alkaline
phosphatase (AP) as a probe, we found that nidogen, an extra-
cellular matrix (ECM) protein, is a candidate ligand for TEM7
in vitro and in vivo.2. Materials and methods
2.1. Cloning of TEM7 and nidogen
Several clones except full length TEM7 and nidogen-Fc were previ-
ously described [4]. Mouse full-length TEM7 was generated with re-
verse transcription-PCR using mouse brain mRNA as template and
the following primers; 5 0-aagcttacctcagtcccgcaacacccgca-30, 5 0-ctcgagg-
cactgctcggcctccacgaa-30. The PCR products were digested with restric-
tion enzymes (HindIII/XhoI), subcloned into the modiﬁed AP5 vector
(Genhunter, Nashville, TN, USA), where AP was removed from the
original plasmid, thereby producing 85 kDa full-length TEM7-
Myc/His without AP-tag. The nidogen-Fc was generated using PCR
with rat brain cDNA, and the following primers were used to generate
105 kDa nidogen; 5 0-aagcttagctacgaggctacagagag-30, 5 0-gcggccgcgc-
agtcaactcccaaggtgtt-3 0. PCR products were digested with restriction
enzymes (HindIII/NotI) and then subcloned into the pIg vector (tagged
with Fc portion of human IgG1), and sequence veriﬁed.
2.2. Cell culture, transfection and production of chimeric molecules
293T cell culture, transfection and Western blot were carried out as
described before [4]. AP and eTEM7-AP proteins were puriﬁed on
nickel beads (Qiagen, Valencia, CA, USA), and Fc fusion proteins
were puriﬁed on protein A-sepharose column (Sigma, St. Louis,
MO, USA) as a standard protocol.
2.3. Solid binding assay and binding aﬃnity
A 96 well plate was coated with various ECM proteins overnight at
4 C, and washed three times with PBS. Conditioned media containing
eTEM7-AP or AP were incubated in the coated plate for 2 h, rinsed
three times with PBS. AP enzyme reaction was done with a substrate
solution buﬀer (1.65 mg/ml of p-nitrophenylphosphate, 0.5 mM
MgCl2, 1 M diethanolamine, pH 9.8), and the reaction products were
measured in a spectrophotometer at 405 nm wave length. To know the
binding aﬃnity between TEM7 ectodomain and nidogen-Fc, eTEM7-
AP proteins were used as binding probes on puriﬁed nidogen-Fc that
was coated on a 96 well plate. The concentration of eTEM7-AP fusion
protein in the conditioned media was estimated by comparison with
the puriﬁed eTEM7-AP. We determined speciﬁcally bound eTEM7-
AP (the values obtained from the diﬀerence between nidogen-Fc and
Fc binding) by measuring the AP enzyme activity.
2.4. Blot overlay assay and ligand binding assay in tissue sections
Matrigel (BD Bioscience, San Jose, CA, USA), ﬁbronectin or
laminin (Sigma) were separated by SDS–PAGE and transferred to a
nitrocellulose membrane (Amersham, Piscataway, NJ, USA). Theblished by Elsevier B.V. All rights reserved.
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solution (10 mM Tris–Cl, 140 mM NaCl, 2 mM EDTA, 2 mM DTT,
0.1% NP-40, pH 7.4). Bound eTEM7-AP was visualized by a chromo-
genic reaction with a mixture of 4-nitroblue tetrazolium chloride
(330 lg/ml) and 5-bromo-4-chloro-3-indolylphosphate (175 lg/ml).
The ligand binding assay in tissue sections was performed as described
by Flanagan et al. [6].
2.5. Cell overlay assay and immunoﬂuorescent staining
293T cells plated on coverslips were transfected with full length
TEM7-Myc or with DCC-Myc construct as a control. Two days after
transient transfection, the cells were incubated with conditioned med-
ium containing nidogen-Fc or Fc for the indicated time, rinsed with
PBS, and ﬁxed with 4% paraformaldehyde in PBS for 10 min. Bound
nidogen-Fc was detected by the sequential incubation of rabbit anti-
human IgG (1/1000) and Alexa 488-conjugated anti-rabbit IgG (Invit-
rogen, Carlsbad, CA, USA), and then immunoﬂuorescent staining
with anti-Myc antibody (1/2000, Santa Cruz Biotechnology, San Die-
go, CA, USA) and Cy3-conjugated secondary antibodies (1/800,
Amersham) were used to reveal cells expressing TEM7-Myc. Fluores-
cence images were acquired on a confocal laser scanning microscope
(LSM510, Carl Zeiss, Germany).
2.6. Preparation of adhesion substrates and cell adhesion/spreading
assays
Coverslips or 24 well plates (Nunc, Rochester, NY, USA) were incu-
bated with puriﬁed nidogen-Fc or Fc or laminin for 2 h. 293T or stable
cell line expressing TEM7 were mechanically dissociated after a brief
exposure of 0.1% trypsin-EDTA, and recovered by subsequent incuba-
tion in 10% FBS containing DMEM for 45 min and 0.5% FBSFig. 1. Identiﬁcation of nidogen as a TEM7-interacting protein in the baseme
used in several binding assays. AP and eTEM7-AP are detected by an anti-M
vessels (arrows) in the spinal cord and endoneurium of the sciatic nerve (ar
eTEM7-AP, binds only to Matrigel. (D) Blot overlay assay shows that eTEM
loaded. Western blot (WB, right panel) using an anti-nidogen antibody demcontaining DMEM for 40 min. Cells were then plated on the diﬀerent
adhesion substrates (4 · 104 cells/well). After 1 h, the attached cells
were photographed and the number of fried egg shaped cells were
counted. The number of attached cells was counted after detachment
by using hemocytometer following trypan blue staining.3. Results and discussion
3.1. Identiﬁcation of nidogen as a TEM7 interacting protein
in vitro
We used a recombinant TEM7 ectodomain fused to alkaline
phosphatase (AP) and Myc/His tags (eTEM7-AP) [4] to screen
the expression of TEM7 ligand in various tissues including the
nervous system. This protein could be detected by Western
blotting in the conditioned medium from transfected human
embryonic kidney-derived 293T cells as a major band of
135 kDa, consistent with the combined sizes of TEM7 ecto-
domain (70 kDa) and AP (67 kDa) (Fig. 1A). When this med-
ium was applied to sections of several tissues, a speciﬁc binding
of eTEM7-AP was detected in the basement membrane of
blood vessels (Fig. 1B). A high expression of eTEM7-AP bind-
ing was also found in the endoneurium of the peripheral nerves
(Fig. 1B). However, the control AP protein did not label the
structures. Since this ﬁnding indicates that the putative
TEM7-interacting molecule appears to be a component ofnt membrane. (A) Western analysis of recombinant AP fusion proteins
yc antibody. (B) Binding of eTEM7-AP to the basement membrane of
rows). Bar, 25 lm. (C) A quantitative solid binding assay shows that
7-AP binds to 105 kDa protein in Matrigel. 5 lg of each protein was
onstrates the presence of 105 kDa nidogen in Matrigel.
Fig. 2. Coimmunoprecipitation and binding aﬃnity of nidogen/TEM7 interaction. (A) Coimmunoprecipitation of eTEM7-AP and nidogen-Fc. The
mixture of secreted fusion proteins from eTEM7-AP and nidogen-Fc transfected 293T cells was precipitated with nickel beads for 2 h at room
temperature. AP and Fc proteins were used as controls. Precipitated proteins were collected by centrifugation and analyzed by Western blot using an
anti-rabbit IgG antibody (1/1000). (B) Equilibrium binding of eTEM7-AP and immobilized nidogen-Fc shows a saturation curve.
Fig. 3. Speciﬁc binding of nidogen-Fc to TEM7-expressing 293T cells. Transiently transfected cells were incubated with Fc or nidogen-Fc containing
conditioned medium. (A) Control Fc does not bind to TEM7 expressing cells. (B) Nidogen-Fc binds to TEM7 expressing cells. The merged image
shows co-localization of nidogen-Fc with TEM7. DAPI staining shows nuclei of 293T cells. (C) Nidogen-Fc does not bind to DCC-myc expressing
293T cells. (D) Nidogen binding to TEM7 induces co-localization of TEM7 and EEA1. Bars, 15 lm.
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ence of TEM7 ligand(s) in Matrigel, a reconstituted basement
membrane [7], using a solid binding assay. eTEM7-AP, but not
control AP, bound to a substrate coated with Matrigel
(Fig. 1C). These results may indicate that the TEM7 ectodo-
main speciﬁcally binds to a component of Matrigel.
To identify the binding partner of TEM7 ectodomain in
Matrigel, we used the blot-overlay assay. This experiment
clearly revealed that eTEM7-AP speciﬁcally interacts with a
protein of 105 kDa only in Matrigel (Fig. 1D), but not with
laminin and ﬁbronectin. The major components of Matrigel
are laminin, collagen type IV, nidogen and some proteogly-
cans. To identify the eTEM7-AP interacting protein(s), Matri-
gel was separated by SDS–PAGE and stained with Coomassie
blue. Protein bands around 105 kDa size were excised and ana-
lyzed by the matrix-assisted laser desorption/ionization time-
of-ﬂight mass spectrometry. This approach demonstrated that
a protein of 105 kDa in Matrigel is nidogen-1 (data not
shown). It is well known that 150 kDa form of unprocessed
nidogen-1 is highly susceptible to proteolytic cleavage and that
amino-terminally cleaved form of 105 kDa nidogen is fre-
quently found in commercially available Matrigel [8] and tissue
samples [9,10]. In accordance with this ﬁnding, a Western blot
of Matrigel with an anti-nidogen antibody showed that the
105 kDa size nidogen is the major form of nidogen in the
Matrigel batch we used (Fig. 1D).
To show direct interaction between eTEM7-AP and nido-
gens, we tested this by asking whether eTEM7-AP wouldFig. 4. Nidogen/TEM7 interaction regulates 293T cell spreading. 293T cells o
on the plates coated with Fc or nidogen-Fc or laminin. (A) TEM7 expressing
fried egg morphology within 30 min. Arrows indicate the peripheral margin of
egg shape (B) or of attached cells (C) after 1 h plating. Values shown are mprecipitate a recombinant nidogen that is fused to the constant
region (Fc) of the human Ig molecule (nidogen-Fc). This
experiment demonstrated that nickel beads speciﬁcally co-pre-
cipitated the eTEM7-AP protein and nidogen-Fc, which could
be detected by a polyclonal anti-human IgG antibody. How-
ever, AP did not co-precipitate nidogen-Fc. (Fig. 2A). Rever-
sely, eTEM7-AP, but not AP, was co-precipitated with
nidogen-Fc by the protein-A agarose (data not shown). We
next estimated the binding aﬃnity for the interactions between
TEM7 ectodomain and nidogen-Fc in an equilibrium binding
experiment (Fig. 2B). Speciﬁc binding of eTEM7-AP to puri-
ﬁed nidogen-Fc showed saturation, yielding values for the Kd
of 10.4 nM. These results indicate that the ectodomain of
TEM7 could bind with high aﬃnity to nidogen in several
in vitro conditions.
3.2. The binding of nidogen to TEM7 in heterologous cells
The availability of nidogen-Fc allowed us to examine the
relationship between nidogen-Fc and full-length TEM7-Myc
in a cell overlay binding assay. In this experiment, nidogen-
Fc binding was found to correlate with TEM7-Myc expression,
providing strong evidence for the binding of nidogen protein to
TEM7 on the cell surface (Fig. 3B). However, control Fc did
not show any positive binding to TEM7-expressing cells
(Fig. 3A). The binding of nidogen-Fc and TEM7 protein in
cells is speciﬁc, as nidogen-Fc did not bind to cells overexpress-
ing unrelated proteins such as deleted in colorectal cancer
(DCC) (Fig. 3C). Interestingly, the binding of nidogen-Fc tor TEM7 expressing stable cells were plated under serum-free conditions
cells, but not control 293T cells, spread on nidogen-Fc exhibited typical
round lamellipodia. (B, C) Quantiﬁcation of the cells showing the fried
eans ± S.D. from three independent experiments.
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orescent structures of TEM7 within 30 min (Fig. 3B and D),
possibly suggesting that TEM7 could be internalized by a stim-
ulation of nidogen in a cell based system. Thus, co-localization
of the endosomal marker EEA1 and TEM7-Myc was analyzed
by confocal microscopy (Fig. 3D). Untreated control cells
expressing TEM7 showed the major localization of TEM7 in
the cytoplasm and plasma membrane (Fig. 3A and D). The
treatment of nidogen-Fc conditioned medium induced loss of
the membrane staining of TEM7 within 1 h. Moreover, it was
observed that the dot-like structures of TEM7 formed by the
treatment of nidogen are considerably co-localized with
EEA1. These results indicate that TEM7 translocates from
the membrane surface to the cytoplasm possibly through the
endocytotic pathway when stimulated with nidogen in a heter-
ologous cell system.
In order to study the possible function of nidogen/TEM7
interaction in vivo, stable clones of TEM7-Myc expressing
cells were generated. Because nidogen is an ECM protein, we
tried to determine whether nidogen aﬀects cell adhesion/
spreading through TEM7. Control cells attach, extend few
lamellipodia and ﬁlopodia within 30 min after plating either
on Fc (10 lg/ml) or nidogen-Fc (10 lg/ml) (Fig. 4A). In con-
trast, TEM7-Myc expressing cells responded to nidogen-Fc
substrate with extensive spreading by 30 min and exhibited a
typical fried egg morphology characterized by a large circular
lamellipodium (62.2 ± 17.8%, P < 0.05, Fig. 4A and B). How-
ever, cell attachment to Fc did not show the extensive spread-
ing (7.1 ± 1.8%). The fried egg shape was also observed in the
transiently transfected 293T cells (data not shown). Both con-
trol cells and TEM7-expressing stable cells grown on laminin
(5 lg/ml) showed similar elongated cell shape characterized
by one or two polarized long processes (Fig. 4A). We next
investigated the eﬀect of nidogen on the cell adhesion ability
of the stable cells, and the result indicates that nidogen-Fc
did not enhance the cell adhesion comparing to Fc (Fig. 4C,
P > 0.05). Taken together, our data suggest that nidogen is a
candidate ligand for TEM7 in vivo.
Nidogens are present in all basement membranes as one of
the major constituents, along with type IV collagen, laminin,
and heparan sulfate proteoglycans [11,12]. Nidogens mediate
the formation of a complex between laminin and type IV col-
lagen, creating the three-dimensional network characteristic of
the basement membranes [11,13]. Besides this structural func-
tion of nidogens, it has long been suggested that nidogens play
a role in cell attachment, chemotaxis of neutrophils, nerve
development, and tumor angiogenesis [14–16]. Some, but not
all, of the nidogen functions are mediated by the integrin
receptor a3b1 [15,17]. However, it is known that the a3b1 inte-
grin is not the receptor only for nidogen but for other matrix
proteins such as laminin [18]. Therefore, it is likely that an-
other speciﬁc receptor for the non-structural functions of nido-
gen is present. In this study, we have shown that TEM7 might
be a novel receptor for nidogen. In terms of tumor angiogen-
esis, the expressions of TEM7 and nidogen are upregulated
[1], and both proteins are known to have angiogenic potentials
in vitro [8,19]. Further studies to reveal the physiological func-
tion of the nidogen/TEM7 interaction in tumor endothelium
are required.Acknowledgements: We thank B. Vogelstein and Z. He for providing
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